Skip to main content
. 2008 Jul;6(4):349–354. doi: 10.1370/afm.861

Table 1.

Skin Disease Incidence and Prevalence, 2002–2006, per 1,000 Patient-Years, by Age and Sex

Skin Disease Total Male Total Female Total Male 0–4 y Female 0–4 y Male 5–14 y Female 5–14 y Male 15–24 y Female 15–24 y Male 25–44 y Female 25–44 y Male 45–64 y Female 45–64 y Male 65–74 y Female 65–74 y Male75 y Female75 y
Acne vulgaris
    Incidence 3.2 2.4 4.1 0.4 0.4 5.6 6.6 13.3 17.3 0.9 4.9 0.0 0.0 0.0 0.4 1.5 0.0
    Prevalence 9.6 5.4 13.7 0.4 0.4 7.2 8.6 35.0 66.9 3.0 18.8 0.2 1.7 0.0 0.4 1.5 0.0
Atopic dermatitis
    Incidence 6.1 6.5 5.7 56.4 40.4 7.4 6.2 2.5 8.4 2.0 2.7 0.9 1.7 0.4 1.1 0.7 0.4
    Prevalence 24.8 23.8 25.7 108.9 77.8 49.9 35.0 18.7 40.6 11.9 22.8 7.6 11.0 11.3 18.2 10.4 11.3
Benign neoplasm
    Incidence 17.5 14.0 20.8 1.2 1.7 2.5 4.4 7.9 16.1 18.4 25.5 19.3 32.1 17.9 23.4 14.2 11.3
    Prevalence 17.6 14.0 21.0 1.2 1.7 2.5 4.4 7.9 16.1 18.4 25.5 19.3 32.4 17.9 24.4 14.2 11.3
Chronic ulcer
    Incidence 2.1 1.7 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 1.5 1.0 5.0 3.6 18.7 27.9
    Prevalence 2.5 2.2 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 1.8 1.0 5.8 3.6 27.6 32.7
Contact dermatitis
    Incidence 2.5 1.5 3.5 0.4 0.8 1.1 1.3 2.2 7.1 1.8 4.3 1.2 4.0 0.8 2.5 3.7 1.3
    Prevalence 4.0 2.2 5.8 0.4 0.8 1.1 1.5 3.2 8.7 2.3 7.0 2.4 7.7 2.9 3.6 3.7 4.4
Corns
    Incidence 3.9 3.4 4.4 0.4 0.0 0.4 0.7 2.2 2.2 3.9 4.0 4.1 5.5 5.0 8.4 10.4 13.1
    Prevalence 4.0 3.4 4.5 0.4 0.0 0.4 0.7 2.2 2.2 3.9 4.2 4.1 5.5 5.0 8.4 10.4 13.1
Dermatitis
    Incidence 53.9 44.0 63.4 62.7 61.0 31.2 41.0 30.2 65.3 35.0 59.3 45.2 66.5 67.1 82.9 100.7 92.0
    Prevalence 64.7 53.4 75.3 64.3 61.4 32.6 43.2 31.5 75.5 42.1 67.0 57.6 84.5 89.6 106.5 147.7 119.9
Diseases of the hair
    Incidence 1.5 0.8 2.1 0.4 0.0 0.7 1.3 0.6 2.2 1.1 3.3 0.9 2.3 0.0 0.7 0.7 0.9
    Prevalence 2.5 1.4 3.7 0.4 0.0 0.9 1.3 0.6 2.2 2.0 4.1 1.8 3.9 0.4 7.6 0.7 6.5
Diseases of the nails
    Incidence 6.8 6.0 7.5 2.4 3.4 4.7 9.3 13.3 8.7 6.6 7.9 4.8 6.0 5.0 8.0 5.2 10.5
    Prevalence 6.8 6.1 7.5 2.4 3.4 4.7 9.3 13.3 8.7 6.7 7.9 5.0 6.0 5.0 8.0 5.2 10.5
Diseases of sebaceous glands and sweat glands
    Incidence 1.8 1.5 2.1 1.2 0.4 0.4 2.6 2.5 4.3 2.1 2.5 1.2 1.6 1.7 0.7 1.4 0.9
    Prevalence 1.9 1.6 2.1 1.2 0.4 0.4 2.6 3.2 4.3 2.2 2.5 1.3 1.6 1.7 0.7 1.4 0.9
Melanoma
    Incidence 0.2 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.2 0.6 0.4 0.7 0.7 0.4
    Prevalence 1.7 1.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 2.2 1.7 4.8 2.1 2.5 6.0 5.2
Pruritus
    Incidence 2.1 1.7 2.4 0.0 0.0 1.1 0.9 0.3 0.9 0.6 2.0 2.4 3.1 3.8 2.2 9.7 10.0
    Prevalence 2.2 19 2.5 0.0 0.0 1.1 0.9 0.3 1.2 0.6 2.2 3.0 3.1 4.6 2.2 9.7 10.0
Psoriasis
    Incidence 1.5 1.3 1.6 0.0 0.4 0.4 0.4 1.9 0.9 1.5 1.9 1.4 2.2 1.7 1.5 2.2 3.1
    Prevalence 15.9 15.5 16.4 0.0 0.4 0.9 0.7 3.8 7.7 13.0 12.8 21.0 20.0 46.2 39.3 46.3 51.9
Sebaceous cyst
    Incidence 10.8 11.2 10.4 0.4 0.4 2.5 0.9 6.7 9.3 15.1 12.4 14.9 13.8 11.3 15.6 17.2 11.8
    Prevalence 10.8 11.2 10.4 0.4 0.4 2.5 0.9 6.7 9.3 15.1 12.4 15.0 13.8 11.3 15.6 17.2 11.8
Seborrheic dermatitis
    Incidence 5.8 5.0 6.5 3.6 7.6 3.8 2.4 3.5 5.6 3.8 6.4 6.3 6.9 9.2 6.2 9.0 13.5
    Prevalence 12.9 12.8 13.0 3.6 7.6 5.4 4.0 7.0 9.0 8.9 11.7 17.4 16.7 20.8 14.9 53.7 31.8
Seborrheic keratosis (wart seborrheic)
    Incidence 7.2 6.2 8.1 0.0 0.0 0.2 0.0 0.3 0.3 2.9 3.7 12.2 16.3 14.6 19.3 21.6 18.7
    Prevalence 7.2 6.3 8.1 0.0 0.0 0.2 0.0 0.3 0.3 2.9 3.7 12.2 16.3 15.0 19.3 21.6 18.7
Squamous cell carcinoma
    Incidence 0.4 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.3 2.9 0.4 4.5 1.7
    Prevalence 0.6 0.8 0.5 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.4 0.5 5.4 0.7 6.0 3.5

Note: Use of patient-years is necessary in long-term follow-up research because not every patient under study can be observed for the same period (because of death, for example). Total number of patient-years in the registry is the sum of the observation period for all observed individuals. In this case, each month within the 5-year period a patient could be observed counts for 1/12 patient year in the total number of patient years in the network.